Invention Grant
- Patent Title: Methods for treating multiple sclerosis using antisense oligonucleotides
-
Application No.: US16622820Application Date: 2018-06-15
-
Publication No.: US11891606B2Publication Date: 2024-02-06
- Inventor: George Tachas
- Applicant: Antisense Therapeutics Ltd
- Applicant Address: AU Victoria
- Assignee: Antisense Therapeutics Ltd
- Current Assignee: Antisense Therapeutics Ltd
- Current Assignee Address: AU Victoria
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: AU 17902314 2017.06.16
- International Application: PCT/AU2018/050598 2018.06.15
- International Announcement: WO2018/227254A 2018.12.20
- Date entered country: 2019-12-13
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61P25/28 ; A61K31/437 ; A61K31/7125 ; A61K38/07 ; A61K38/21 ; C12Q1/68
Abstract:
A method for treating a patient suffering from multiple sclerosis, including progressive forms of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE I to the patient, thereby treating the patient.
Public/Granted literature
- US20210147851A1 METHODS FOR TREATING MULTIPLE SCLEROSIS USING ANTISENSE OLIGONUCLEOTIDES Public/Granted day:2021-05-20
Information query
IPC分类:
